SignatureFD’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-99
| Closed | -$10.1K | – | 3339 |
|
2023
Q2 | $10.1K | Buy |
99
+6
| +6% | +$612 | ﹤0.01% | 2229 |
|
2023
Q1 | $8.46K | Buy |
93
+8
| +9% | +$727 | ﹤0.01% | 2285 |
|
2022
Q4 | $3.23K | Buy |
85
+25
| +42% | +$950 | ﹤0.01% | 2638 |
|
2022
Q3 | $2K | Sell |
60
-58
| -49% | -$1.93K | ﹤0.01% | 2873 |
|
2022
Q2 | $4K | Sell |
118
-157
| -57% | -$5.32K | ﹤0.01% | 2565 |
|
2022
Q1 | $9K | Buy |
+275
| New | +$9K | ﹤0.01% | 2226 |
|
2021
Q4 | – | Sell |
-35
| Closed | -$4K | – | 3321 |
|
2021
Q3 | $4K | Sell |
35
-8
| -19% | -$914 | ﹤0.01% | 2473 |
|
2021
Q2 | $6K | Buy |
43
+18
| +72% | +$2.51K | ﹤0.01% | 2237 |
|
2021
Q1 | $2K | Buy |
25
+16
| +178% | +$1.28K | ﹤0.01% | 2550 |
|
2020
Q4 | $1K | Sell |
9
-5
| -36% | -$556 | ﹤0.01% | 2497 |
|
2020
Q3 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 2519 |
|